Let's hope things unfold as you envision. I'm concerned that Armistice may be predators who want to kill the company and sell the carcass for a quick 40% profit or they are just greenmailers looking to shake the company down.
Do you know about how ling it is likely to take to resolve such a stockholder lawsuit? Will there be enough time for the CE Melphalan decision in October to be reached and the Apaziquone filing to be completed in December? Both events are likely to have a positive impact on the share price - in the market or in a corporate sale.
A timeframe of "years" for the suit is reassuring. Hopefully, Armistice has lit a fire under some decision-making butts at Spectrum. Hopefully by the time a sale is even contemplated (if it comes to that) Spectrum will be a much improved company. Thanks for answering my question. Much appreciated.
Spectrum has dealt with activist investors before. They have (a) beaten them back, (b) gained experience in the process and (c) installed a poison pill shelf registration of many millions of additional shares they can float to discourage unwanted suitors or raiders.
Does anyone have a handle (not just speculation) on (a) how likely it is that Armistice will succeed and, if unlikely, (b) what the probable outcome(s) of this confrontation would be?